Çѱ¹ÀÇÇÐ³í¹® µ¥ÀÌÅͺ£À̽º
Á¦¸ñ 4¿ù ÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®

 

4¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ Å°¿öµå ¹× ³×Æ®¿öÅ© ºÐ¼®

 

 


 

                        ±×¸² 1.   ÀÇ°úÇÐ 4¿ù ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå




 

4¿ù¿¡ ÀÇ°úÇÐºÐ¾ß ±¹³»Àú³Î°ú ±¹Á¦ Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹®Àº  ÃÑ 3,397ÆíÀ¸·Î Àü¿ù¿¡ ºñ±³ÇÏ¿© 3,908ÆíÀ¸·Î Àü¿ù¿¡ ºñÇÏ¿© 511Æí °¨¼ÒÇÑ Ãß¼¼ÀÌ´Ù. ÀÇ°úÇÐ ºÐ¾ßº° ¹ßÇ¥ÇöȲÀ» »ìÆ캸¸é ÀÓ»óÀÇÇÐ 1,792Æí, ±âÃÊÀÇÇÐ 1,016Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 407Æí, °£È£ÇÐ 91Æí, Ä¡ÀÇÇÐ 91ÆíÀ¸·Î ³ªÅ¸³µ´Ù. ÀÇ°úÇÐºÐ¾ß ±¹³» Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹®Àº 1,379ÆíÀ¸·Î ³ªÅ¸³µÀ¸¸ç, ±¹Á¦ Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹®Àº 2,018ÆíÀ¸·Î ³ªÅ¸³ª, ±¹³»Àú³Îº¸´Ù ÇØ¿ÜÀú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹®ÀÌ 46%ÀÌ»ó ³ô°Ô ³ªÅ¸³µ´Ù. 

 

Ç¥ 1. 4¿ù ÀÇ°úÇÐ ÅëÇÕ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(N=3,397)  

Å°¿öµå ¼øÀ§

±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ

ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

1

Women

Risk

Risk

2

Risk

Neoplasms

Neoplasms

3

Neoplasms

Genes

Women

4

General Surgery

Women

Genes

5

COVID-19

Attention

COVID-19

6

Pediatrics

Humans

Role

7

Genes

Role

General Surgery

8

Complication

Survival Rate

Humans

9

Role

Sensitivity And Specificity

Attention

10

Depression

COVID-19

Pediatrics






 

                 ±×¸² 2. ±¹³» Àú³Î ¹ßÇ¥ 4¿ù ÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼® 








 

 

               ±×¸² 3. ±¹¿Ü Àú³Î ¹ßÇ¥ 4¿ù ÀÇ°úÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®




 

Ç¥  2. ÀÇ°úÇР 4¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ   

Topic1

Topic2

Topic3

Topic4

Topic5

COVID-19

Complication

Genes

Survival Rate

Women

Vaccination

Risk

Attention

Mortality

Depression

Technology

General Surgery

Role

Neoplasms

Risk

Role

Sensitivity And Specificity

Water

Risk

Older Adults

Environment

Stroke

Economics

Recurrence

Pediatrics

Evaluation Studies As Topic

Drug

Humans

Neoplasm Metastasis

Adult

Health Care Costs

F-18 Fdg Pet

Nanoparticles

Liver

Exercise

Learning

Pain

Apoptosis

Drug Therapy

Adolescent

Education

Women

DNA

Serum

Sleep

Forecasting

Mortality

In Vitro Techniques

Breast Neoplasms

Behavior

 




 

±×¸² 4.  ±¹³» ±¹¿Ü ÅëÇÕ ÀÇ°úÇР Å°¿öµå ÃßÃâ  ¸ðµ¨¸µ ³×Æ®¿öÅ©  ºÐ¼®



 

ÀÇ°úÇÐ ºÐ¾ß ¿¬±¸ Å°¿öµå´Â À§±â(Risk), Á¾¾ç(Neoplasms), ¿©¼º(Women), À¯ÀüÀÚ(Genes), Äڷγª19(COVID-19), ¿ªÇÒ(Role), ¼ö¼ú(General Surgery), ÁýÁß(Attention), ¼Ò¾Æ(Pediatrics), »ýÁ¸À²(Survival Rate), »ç¸Á·ü(Mortality), ¹Î°¨µµ¿Í Ÿ´çµµ(Sensitivity & Specificity) µîÀÌ »óÀ§·Î ³ªÅ¸³µ´Ù.  À§±â(Risk), Á¾¾ç(Neoplasms)¸¦ Æ÷ÇÔÇÏ¿© COVID-19¿Í °ü·ÃµÈ °³³äÀÎ Complication, Mortality µîÀÇ °³³äÀº ÀÓ»óÀÇÇÐ, ±âÃÊÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀ¸·Î ÁÖ¿ä °ü½É ÁÖÁ¦·Î ³ªÅ¸³µ´Ù.  ÀÇ°úÇבּ¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹®µ¥ÀÌÅÍ´Â 2022³â 4¿ù¿¡ ±¹³»¿Í ±¹¿Ü Àú³ÎÀ» ÅëÇØ  ¹ßÇ¥µÈ ³í¹® Áß¿¡¼­ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í Æà¸Þµå(PubMed) µ¥ÀÌÅͺ£À̽º¿¡ À妽ºµÈ ³í¹®ÀڷḦ ÃßÃâÇÏ¿© ÀÇ°úÇÐ Àüü ±¹³»Àú³Î ¹× ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ Å°¿öµå¸¦ ÅëÇÕ ºÐ¼®ÇÏ¿´´Ù. 





 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø






 

* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼­ ¼­ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.



 


2022-05-19 ¿ÀÈÄ 4:49:43, Á¶È¸¼ö : 931